Androgenetic alopecia as a cardiovascular risk factor

Wernicka, Aneta; Wyzgał, Maciej; Waśkiel‐Burnat, Anna; Sikora, Mariusz

doi:10.5114/dr.2018.80841

Cited by 2 publications

(3 citation statements)

References 43 publications

(110 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Acanthosis nigricans may be one of the first manifestations of insulin resistance [45,46]. Severe early-onset androgenic alopecia, both in women and in men, is an indicator of increased cardiovascular risk [47]. The most important cutaneous lesions associated with cardiovascular diseases are listed in table 2.…”

Section: Cutaneous Manifestations Of Cardiovascular Diseasesmentioning

confidence: 99%

“…Rogowacenie ciemne (acanthosis nigricans) mogą być jednym z pierwszych objawów świadczących o insulinooporności [45,46]. Łysienie androgenowe o wczesnym początku i dużym nasileniu, zarówno u kobiet, jak i mężczyzn, wskazuje na zwiększone ryzyko sercowo-naczyniowe [47]. Podsumowanie najważniejszych zmian skórnych w chorobach układu sercowo-naczyniowego przedstawiono w tabeli 2.…”

Section: Conflict Of Interestunclassified

See 1 more Smart Citation

Cardiodermatology in the physician’s practice

Ryś-Czaporowska¹,

Płatek²,

Sikora³

et al. 2019

Self Cite

View full text Add to dashboard Cite

Cardiovascular diseases are the leading cause of hospitalization and mortality across the world. In 2013, the estimated number of deaths from cardiovascular diseases exceeded 17 million, accounting for 31.5% of all deaths globally, i.e. twice the number of all cancer-related deaths The article explores the correlation between selected dermatological diseases and an elevated risk of cardiovascular events. In addition, cutaneous manifestations of cardiovascular diseases which are important in the physician's practice, and therapeutic dilemmas involved in the coexistence of cardiac and dermatological diseases, are discussed. streszczenie Choroby układu sercowo-naczyniowego stanowią główną przyczynę hospitalizacji i zgonów na świecie. W 2013 roku liczbę zgonów z powodu chorób układu krążenia oszacowano na ponad 17 milionów, co stanowiło 31,5% ogółu zgonów na świecie, dwukrotnie przewyższając liczbę zgonów z powodu chorób nowotworowych. W artykule przeanalizowano związek wybranych chorób dermatologicznych ze zwiększonym ryzykiem wystąpienia incydentów sercowo-naczyniowych. Ponadto przedstawiono ważne z praktycznego punktu widzenia skórne objawy chorób układu krążenia oraz dylematy terapeutyczne w przypadku współistnienia chorób kardiologicznych i dermatologicznych.

show abstract

Section: Cutaneous Manifestations Of Cardiovascular Diseasesmentioning

confidence: 99%

Section: Conflict Of Interestunclassified

Cardiodermatology in the physician’s practice

Ryś-Czaporowska¹,

Płatek²,

Sikora³

et al. 2019

Self Cite

View full text Add to dashboard Cite

show abstract

“…Many studies indicate a link between androgenetic alopecia and an increased risk of cardiovascular diseases. In addition, people with androgenetic alopecia are more likely to develop atherosclerosis, hypertension, and even insulin resistance (IO) and obesity [10].…”

Section: Introductionmentioning

confidence: 99%

Medicinal and cosmetic products used in treatment of hair loss

Abramek,

Naja-Wiśniewska,

Nieradko-Iwanicka

2023

Polish Hyperbaric Research

View full text Add to dashboard Cite

Hair loss or alopecia is a reduction in the volume or complete loss of hair and is a fairly common clinical problem, especially in the geriatric population. Androgenetic alopecia (AGA) is the most common type of hair loss in men. Androgenetic alopecia in women most often occurs before the age of 60. We also distinguish androgenetic alopecia in postmenopausal women and scarring, areata, telogen and drug-induced alopecia. The aim of the study was to analyze the composition of medicinal and cosmetic preparations available on the Polish market, recommended for people struggling with alopecia. In 2022, the composition of preparations used in alopecia available in pharmacies and drugstores was analyzed. In total 57 medicinal and cosmetic preparations recommended for people suffering from alopecia have been identified. The most common active substance in the analyzed preparations is finasteride. Frequently used active substances are biotin and minoxidil, rarely prednisolone. Conclusions: 1. In preparations intended for people with alopecia, the most frequently used active substance is finasteride. 2. Statistically, preparations for hair loss are most often in the form of tablets and shampoos. 3. The analyzed preparations for alopecia belong to the category of prescription drugs and cosmetics, less often in the category of OTC drugs or dietary supplements.

show abstract

Androgenetic alopecia as a cardiovascular risk factor

Cited by 2 publications

References 43 publications

Cardiodermatology in the physician’s practice

Cardiodermatology in the physician’s practice

Medicinal and cosmetic products used in treatment of hair loss

Contact Info

Product

Resources

About